Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Parkinsonism & Related Disorders
|
October 17, 2021
Low soluble amyloid-β 42 is associated with smaller brain volume in Parkinson's disease
Alberto J Espay, David-Erick Lafontant, Kathleen L Poston, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 17, 2024
Eleven Years of Change: Disease Progression in Biomarker-Defined Sporadic Parkinson's Disease
Paulina Gonzalez-Latapi, Caroline Gochanour, Hyunkeun Cho, et al.
Journal of Clinical and Translational Science
|
September 22, 2025
Community engagement strategies improve recruitment and enrollment in a pragmatic clinical trial
Kari G Vance, Jonah Pedelty, Barbara J Van Gorp, et al.
Annals of Clinical and Translational Neurology
|
March 11, 2026
Five-Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease
Paulina Gonzalez-Latapi, Caroline Gochanour, Seung Ho Choi, et al.
JAMA Neurology
|
December 14, 2020
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial
Tanya Simuni, Brian Fiske, Kalpana Merchant, et al.
Acta Neuropathologica Communications
|
November 7, 2021
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease
Marco J Russo, Christina D Orru, Luis Concha-Marambio, et al.
Physical Therapy
|
August 29, 2022
The Fibromyalgia Transcutaneous Electrical Nerve Stimulation in Physical Therapy Study Protocol: A Multisite Embedded Pragmatic Trial
Andrew A Post, Dana L Dailey, Emine O Bayman, et al.
Annals of Neurology
|
May 19, 2026
Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative
Paulina Gonzalez-Latapi, Caroline Gochanour, Seung Ho Choi, et al.
Annals of Clinical and Translational Neurology
|
April 22, 2026
Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker-Defined Synucleinopathy
Daniel Weintraub, Michele K York, Roseanne Dobkin, et al.
Brain Communications
|
March 21, 2025
<i>LRRK2</i>-associated parkinsonism with and without <i>in vivo</i> evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization
Lana M Chahine, David-Erick Lafontant, Seung Ho Choi, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Parkinsonism & Related Disorders
|
October 17, 2021
Low soluble amyloid-β 42 is associated with smaller brain volume in Parkinson's disease
Alberto J Espay, David-Erick Lafontant, Kathleen L Poston, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 17, 2024
Eleven Years of Change: Disease Progression in Biomarker-Defined Sporadic Parkinson's Disease
Paulina Gonzalez-Latapi, Caroline Gochanour, Hyunkeun Cho, et al.
Journal of Clinical and Translational Science
|
September 22, 2025
Community engagement strategies improve recruitment and enrollment in a pragmatic clinical trial
Kari G Vance, Jonah Pedelty, Barbara J Van Gorp, et al.
Annals of Clinical and Translational Neurology
|
March 11, 2026
Five-Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease
Paulina Gonzalez-Latapi, Caroline Gochanour, Seung Ho Choi, et al.
JAMA Neurology
|
December 14, 2020
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial
Tanya Simuni, Brian Fiske, Kalpana Merchant, et al.
Acta Neuropathologica Communications
|
November 7, 2021
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease
Marco J Russo, Christina D Orru, Luis Concha-Marambio, et al.
Physical Therapy
|
August 29, 2022
The Fibromyalgia Transcutaneous Electrical Nerve Stimulation in Physical Therapy Study Protocol: A Multisite Embedded Pragmatic Trial
Andrew A Post, Dana L Dailey, Emine O Bayman, et al.
Annals of Neurology
|
May 19, 2026
Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative
Paulina Gonzalez-Latapi, Caroline Gochanour, Seung Ho Choi, et al.
Annals of Clinical and Translational Neurology
|
April 22, 2026
Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker-Defined Synucleinopathy
Daniel Weintraub, Michele K York, Roseanne Dobkin, et al.
Brain Communications
|
March 21, 2025
<i>LRRK2</i>-associated parkinsonism with and without <i>in vivo</i> evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization
Lana M Chahine, David-Erick Lafontant, Seung Ho Choi, et al.
Page
of 3